← Back
$AVDL All transactions

AVADEL PHARMACEUTICALS PLC

A

$ Value

$0

Shares

11,000

Price

$0

Filed

Jul 31

Insider

Name

Thornton Peter J.

Title

CIK

0001295432

Roles

Director

Transaction Details

Transaction Date

2025-07-29

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

11,000

Footnotes

Represents a restricted share award. The shares shall vest in full on the earlier to occur of (a) July 29, 2026 or (b) the date of the next annual general meeting of shareholders following the date of grant, subject to the Reporting Person's continued service at such time. | The options shall vest in full on the earlier to occur of (a) July 29, 2026 or (b) the date of the next annual general meeting of shareholders following the date of grant, subject to the Reporting Person's continued service at such time.

Filing Info

Accession No.

0001104659-25-072687

Form Type

4

Issuer CIK

0001012477

Thornton Peter J.'s History

Date Ticker Type Value
2026-02-12 AVDL D $2.4M
2026-02-12 AVDL D
2026-02-12 AVDL D
2026-02-12 AVDL D
2026-02-12 AVDL D
2026-02-12 AVDL D
2026-02-12 AVDL D
2026-02-12 AVDL D
2025-07-29 AVDL A $0
2025-07-29 AVDL A $0

Other Insiders at AVDL (90d)

Insider Bought Sold Last
MCHUGH THOMAS S
Chief Financial Officer
2026-02-12
Thornton Peter J. 2026-02-12
Weiss Asset Management LP $233.4M 2026-02-13
McCamish Mark Anthony 2026-02-12
Divis Gregory J
Chief Executive Officer
2026-02-12
Ende Eric J 2026-02-12
Glass Geoffrey Michael 2026-02-12
Amin Naseem 2026-02-12
Palczuk Linda 2026-02-12
Rodriguez Susan
Chief Operating Officer
2026-02-12
Seurer Jerad G.
Gen. Counsel & Corp. Secretary
2026-02-12